About William Canestaro
Form D filings for Lila Biologics in 2023 list William Canestaro as director.
William Canestaro first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name William Canestaro in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people William Canestaro works with at each company, as listed on that company's latest Form D.
Lila Biologics, Inc. · Form D, Sep 28, 2023
SG
Sheila Gujrathi
Director
JI
John Kraft, II
Chief Executive Officer and director
AR
Anindya Roy
Executive officer and director